Anesth Analg 2001;93:1018-1024
© 2001 International Anesthesia Research Society
PAIN MEDICINE
The Synergistic Antinociceptive Interactions of Endomorphin-1 with Dexmedetomidine and/or S(+)-Ketamine in Rats
Gyöngyi Horvath, MD PhD* ,
Gabriella Joo, PhD ,
Ildiko Dobos ,
Walter Klimscha, MD ,
Geza Toth, PhD , and
György Benedek, MD DSc
*Department of Physical Therapy, Faculty of Health Science, and Department of Physiology, Faculty of Medicine, University of Szeged, Szeged, Hungary; Department of Anesthesiology and Intensive Care, University of Vienna, Austria; and Isotope Laboratory of Biological Research Center of the Hungarian Academy of Sciences, Szeged, Hungary
Address correspondence and reprint requests to Gyöngyi Horvath, Department of Physiology, Faculty of Medicine, University of Szeged, P.O.B: 427; H-6701, Szeged, Hungary. Address e-mail to horvath{at}phys.szote.u-szeged.hu
Spinal administration of the endogenous µ-opioid agonist peptide, endomorphin-1, results in antinociception in rodents, but there are few data about its interaction with other antinociceptive drugs. We investigated the antinociceptive interactions at the spinal level of endomorphin-1 with the N-methyl-D-aspartate antagonist S(+)-ketamine, the 2-adrenoceptor agonist dexmedetomidine, or both in awake rats. Nociception was assessed by the tail-flick test. Dose-response curves were determined for endomorphin-1 (0.650 µg), for dexmedetomidine (0.110 µg), for mixtures of S(+)-ketamine (30 or 100 µg) with endomorphin-1 (218 µg) or of endomorphin-1 with dexmedetomidine in a fixed ratio (4:1), and for the triple combination of the three drugs after intrathecal administration. Endomorphin-1 and dexmedetomidine both produced dose-dependent antinociception. The coadministration of 100 µg S(+)-ketamine significantly enhanced the antinociceptive effect of 6 µg endomorphin-1. Isobolographic analysis of the combinations of endomorphin-1 and dexmedetomidine revealed a synergistic interaction between these drugs. The 80% effective dose for the triple combination was significantly less than that for either binary combination. These data indicate that S(+)-ketamine and dexmedetomidine, acting via different receptors, produce synergistic antinociceptive interaction with endomorphin-1 at the spinal level. Furthermore, the triple combination of an opioid agonist, an 2-adrenoceptor agonist, and an N-methyl-D-aspartate receptor antagonist shows potent antinociceptive activity.
IMPLICATIONS: The coadministration of the N-methyl-D-aspartate antagonist receptor antagonist, S(+)-ketamine, or the specific 2-adrenoceptor agonist, dexmedetomidine, significantly enhances the antinociceptive effect of the endogenous µ-opioid agonist, endomorphin-1, at the spinal level. The triple combination of the three drugs causes a further improved antinociception.
This article has been cited by other articles:

|
 |

|
 |
 
G. Niraj, A. Searle, M. Mathews, V. Misra, M. Baban, S. Kiani, and M. Wong
Analgesic efficacy of ultrasound-guided transversus abdominis plane block in patients undergoing open appendicectomy
Br. J. Anaesth.,
October 1, 2009;
103(4):
601 - 605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Mecs, G. Tuboly, E. Nagy, G. Benedek, and G. Horvath
The Peripheral Antinociceptive Effects of Endomorphin-1 and Kynurenic Acid in the Rat Inflamed Joint Model
Anesth. Analg.,
October 1, 2009;
109(4):
1297 - 1304.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|